Open help menu
Live Webinar

AI in OCD Treatment: Clinical Promise, Ethical Risks, and Practical Applications

Meredith Hettler, MS, LMFT, CCAPT
|

Information

Date & Time

Description

Artificial intelligence (AI) is rapidly becoming embedded in mental healthcare, and people with obsessive-compulsive disorder (OCD) are turning to AI-based tools for support, information and symptom management. While AI can potentially enhance psychoeducation, treatment planning, and Exposure and Response Prevention (ERP) therapy, it also introduces significant risks. This presentation examines the evolving role of AI in OCD treatment through a clinical, ethical, and practical lens.

Learning Objectives

Participants will be able to:

  • Identify clinical risks associated with AI-based reassurance-seeking and its impact on symptom maintenance and treatment interference

  • Evaluate the potential benefits and limitations of AI as an adjunctive tool in evidence-based OCD treatment

  • Apply ethical and clinical guidelines for addressing AI use within OCD assessment, treatment planning, and exposure development

Educational Goal

The educational goal of this workshop is for participants to describe the evolving role of AI in OCD treatment through a clinical, ethical, and practical lens.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Psychologist
  • Social Worker

Presenters

Meredith Hettler, MS, LMFT, CCAPT
​ Meredith Hettler, MS, LMFT, CCAPT is the National Director of Newport Healthcare's OCD and Anxiety Program. She has more than 15 years of experience in the behavioral healthcare field, and specializes in working with adolescents and young adults, using modalities including Exposure and Response Prevention therapy, ACT Attachment-Based Family Therapy and Cognitive Behavioral Therapy

Financially Sponsored By

  • Newport Healthcare